Myristoyl/Palmitoyl Oxostearamide/Arachamide Mea

Myristoyl/Palmitoyl Oxostearamide/Arachamide Mea (M/PO/AM) is a synthetic pseudoceramide; it's basically a lab-made ingredient designed to mimic the ceramides that your skin naturally produces.

What makes this ingredient special? It is connected to something called multi-lamellar emulsion (MLE) technology.

Your skin's outermost layer (stratum corneum) is often described as a "brick wall" where skin cells are bricks and lipids hold everything together. Your lipids are Ceramides, Cholesterol, and free fatty acids.

These fatty acids are not just randomly squished together. They're arranged in very specific layered (lamellar) structures. Your barrier suffers when the layer structure gets disrupted from things like eczema, harsh weather, or over-exfoliating.

M/PO/AM is formulated within MLE technology to closely replicate your skin's natural layers, setting it apart from other ceramides.

The research behind M/PO/AM is pretty solid for eczema, aka atopic dermatitis. A 2003 study on children with eczema found that an MLE cream containing M/PO/AM outperformed a standard urea-based moisturizer. The study also found a 31-35% decrease in severity index compared to smaller improvements from the control cream.

Recently, a 2024 trial found that combining M/PO/AM with topical corticosteroid led to better outcomes than using the steroid alone. The trial noted improvements in skin hydration, dryness, itching, and quality of life scores.

Research has also shown that M/PO/AM can help reduce barrier-damaging side effects of long term topical steroid use.

This ingredient also goes by the trade name PC-9S. No notable allergy concerns have been flagged for this ingredient in the published literature.